Skip to content

Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies

Creation of a Bank of Biological Material From Patients and Healthy Donors (Biobank) for the Study of Urological and Uro-oncological Pathologies - URBBAN

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06187870
Enrollment
15000
Registered
2024-01-03
Start date
2010-10-07
Completion date
2030-10-06
Last updated
2024-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Urologic Cancer, Urologic Diseases

Brief summary

The project aims to collect fresh biological material derived both from surgical resections performed in diseases, neoplastic and otherwise, of urological relevance at the level of the prostate, bladder, kidney, testicle and genitourinary organs, and from peripheral blood or other fluids biological samples such as urine, seminal fluid, buccal mucosa, feces or saliva, when available.

Detailed description

Significant studies have shown the great potential of research based on access to biobanks which has made it possible to conduct studies and obtain important results through retrospective studies carried out on samples collected some time ago. Thanks to the possibility of accessing human biological samples collected and stored in biological banks, great results have been achieved in the medical field. The project aims to collect fresh biological material deriving from surgical resections performed in neoplastic and non-neoplastic pathologies of urological relevance at the level of the prostate, bladder, kidney, testicle and genitourinary organs, both from biological samples of peripheral blood or other fluids such as urine, seminal fluid, buccal mucosa, feces or saliva, when available. The possibility of obtaining biological samples from the patient at the time of the first visit or the first biopsy and, subsequently, in conjunction with a possible surgical intervention, could ideally give the possibility of studying the disease from its possible onset to the possible intervention, evaluating the evolution and possible association with circulating diagnostic and prognostic markers. The establishment of this collection of research material will allow access to samples of extreme value for the pathophysiological study of the disease, its origin, mechanisms and markers of progression. The data obtained can also be correlated with the patient's clinical history in order to build an overall vision potentially useful in the design of new therapeutic strategies.

Interventions

Biological samples will be collected from the patient at the time of their access to the Hospital

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female patients with an age \> 18 * Ability to read and sign the informed consent * patients affected by urological or uro-oncological diseases

Exclusion criteria

* People with an age \< 18 * Incapacity to read and sign the informed consent

Design outcomes

Primary

MeasureTime frameDescription
Biological sampleBaselineA biobank is a facility aimed at the collection, management, preservation and distribution of biomaterials and related data for research purposes

Countries

Italy

Contacts

Primary ContactAnna Maria Ferrara
ferrara.annamaria@hsr.it0226437795

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026